28/01/2011 - General information
Laura López, Cristian Obiol-Pardo and Jana Selent, members of the Computer Aided Drug Design (CADD) group of the Biomedical IT Research Group (GRIB, of the UPF-IMIM) have won first prize for the best prediction of the ligands established by the GPCR protein, a molecule which intervenes in many cell processes and interacts with half of all known drugs.
Més informació "GRIB Members Win an International Competition"
27/01/2011 - Institutional news
Jordi Mestres at the Editorial Board of the new publication "Scientific Reports" Jordi Mestres, head of Chemogenomics laboratory of GRIB (IMIM-UPF) has been appointed member of the Editorial Board of Scientific Reports, the new primary research publication from the publishers of Nature, covering all areas of the natural sciences –biology, chemistry, physics, and earth sciences.
Més informació "Jordi Mestres at the Editorial Board of the new publication "Scientific Reports"
21th december 2010 - Press release
Triple-negative breast cancer (Estrogen Receptor-Negative, Progesterone Receptor-Negative, and HER-Negative) is a type of breast cancer with clinical characteristics and specific pathologies that represents a relevant clinic problem, as it affects around 20% of all women with breast cancer, and especially those who are young.
16/12/2010 - General information
In November, the IMIM Anti-Doping Control Laboratory, directed by Dr. Jordi Segura, celebrated 25 years of history. Ever since it was first accredited by the International Olympic Committee in 1985, its objective has always been to offer high quality, reliable services. It is currently made up of a team of around 30 people from various disciplines and origins, all of whom have extensive experience in the doping field.
Més informació "25 years of the IMIM Anti-Doping Control Laboratory"
13/12/2010 - General information
In connection with this, the meeting of the WADA Lab Committee, chaired by Toni Pascual, took place in the IMIM on the 9th and 10th December past. This committee is made up of an international group of experts on doping and is the advisory body in charge of all aspects related to the work carried out by anti-doping control laboratories on a global scale
30/11/2010 - Institutional news
The prize-giving ceremony for the Awards for Professional Excellence 2010, organised by the Barcelona College of Doctors (COMB), took place on the 29th November in the Teatro Romea. Roberto Elosua, coordinator of the IMIM Cardiovascular Genetics and Epidemiology Research Group, received an award at this year’s ceremony along with other professionals from MAR Health Park.
Més informació "Roberto Elosua wins the COMB Award for Professional Excellence"
16/11/2010 - General information
A study directed by Miguel López-Botet, director of the IMIM (Hospital del Mar Research Institute) and coordinator of the Immunology Laboratory of the Health and Experimental Science Department (CEXS), has identified the receptors involved in triggering the cytotoxic activity of human NK (natural killer) cells in response to human cytomegalovirus (HCMV)-infected dendritic cells.
16/11/2010 - Press release
A study jointly led by researchers from the Hospital del Mar and the IMIM in Barcelona, Regensburg University (Germany) and the Epithelial Carcinogenesis group of the Molecular Pathology Programme at the National Centre for Cancer Research (CNIO, Centro Nacional de Investigaciones Oncológicas) has explained new aspects regarding the genetics of benign skin tumours which question how tumours develop and progress.
Més informació "Benign skin tumours provide clues to the molecular mechanisms involved in cancer"
16/11/2010 - Press release
One of the grants awarded by the European Research Council (ERC) this year was for the BREATHE (BRain dEvelopment and Air polluTion ultrafine particles in scHool ChildrEn) project directed by Dr. Jordi Sunyer, co-director of the Research Centre for Environmental Epidemiology (CREAL) and director of the IMIM Research Programme in Epidemiology and Public Health.
Més informació "Jordi Sunyer has been awarded the Advanced Grant for scientific excellence"
08/11/2010 - Press release
A study in Barcelona led by Dr. Silvia Delgado of the Hospital del Mar Digestion Service and IMIM researcher at the Hospital del Mar Research Institute, shows that speeding up the arrival of nutrients into the intestine with a drug manages to reduce the amount of food consumed in one meal. These results have been published in the International Journal of Obesity and involve a change of paradigm with regard to the established knowledge on the mechanisms which control satiety and ingestion in humans.
Més informació "A new treatment option for fighting obesity has been identified"
Servei de Comunicació:
Marta Calsina Freixas(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact